Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent

NCT00910299 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00910299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00910299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Prasugrel Versus Clopidogrel in Subjects With High Platelet Reactivity on Clopidogrel Following Elective Percutaneous Coronary Intervention With Implantation of Drug-Eluting Stent
Lead sponsor
Eli Lilly and Company
Phase
Phase 2
Overall status
Terminated
Start date
July 31, 2009
Completion date
April 30, 2011
Enrollment
423 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease (cad)